Thinle Chodon

7.4k total citations · 3 hit papers
33 papers, 5.2k citations indexed

About

Thinle Chodon is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Thinle Chodon has authored 33 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Thinle Chodon's work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Thinle Chodon is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Thinle Chodon collaborates with scholars based in United States, Australia and Japan. Thinle Chodon's co-authors include Antoni Ribas, Richard C. Koya, Hubing Shi, Xiangju Kong, Roger S. Lo, Jeffrey A. Sosman, Mi‐Kyung Lee, Hane Lee, Stanley F. Nelson and Narsis Attar and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Thinle Chodon

33 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

2010 1.6k citations Ramin Nazarian, Hubing Shi et al. Nature profile →
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

2013 715 citations Hubing Shi, Willy Hugo et al. Cancer Discovery profile →
Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance

2012 470 citations Hubing Shi, Gatien Moriceau et al. Nature Communications profile →

Peers

Countries citing papers authored by Thinle Chodon

Since Specialization

Citations

This map shows the geographic impact of Thinle Chodon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thinle Chodon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thinle Chodon more than expected).

Fields of papers citing papers by Thinle Chodon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thinle Chodon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thinle Chodon. The network helps show where Thinle Chodon may publish in the future.

Co-authorship network of co-authors of Thinle Chodon

This figure shows the co-authorship network connecting the top 25 collaborators of Thinle Chodon. A scholar is included among the top collaborators of Thinle Chodon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thinle Chodon. Thinle Chodon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction 2022 ·Cancer Immunology Immunotherapy ·(unknown), Takemasa Tsuji, Junko Matsuzaki, Hemn Mohammadpour, Cheryl Eppolito, Sebastiano Battaglia, Fumito Ito, Thinle Chodon, Richard C. Koya, AJ Robert McGray, Kunle Odunsi	4
2	Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies 2019 ·Advances in experimental medicine and biology ·Satoko Matsueda, Thinle Chodon, Richard C. Koya	3
3	A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells 2019 ·Journal for ImmunoTherapy of Cancer ·Junko Matsuzaki, Takemasa Tsuji, Thinle Chodon, (unknown), Richard C. Koya, Kunle Odunsi	16
4	PD-1 Blockade Expands Intratumoral Memory T Cells 2016 ·Cancer Immunology Research ·Antoni Ribas, Daniel Sanghoon Shin, Jesse M. Zaretsky, Juliet Frederiksen, Andrew Cornish, Earl Avramis, Elizabeth Seja, Christine Kivork, Janet Siebert, Paula Kaplan‐Lefko, Xiaoyan Wang, Bartosz Chmielowski, John A. Glaspy, Paul C. Tumeh, Thinle Chodon, Dana Pe’er, Begoña Comı́n-Anduix	302
5	Active Immunotherapy of Cancer 2015 ·Immunological Investigations ·Thinle Chodon, Richard C. Koya, Kunle Odunsi	40
6	Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma 2014 ·Clinical Cancer Research ·Mohammad Atefi, Earl Avramis, Amanda Lassen, Deborah J. Wong, Lídia Robert, David Foulad, Michael Cerniglia, Bjoern Titz, Thinle Chodon, Thomas G. Graeber, Begonya Comin-Anduix, Antoni Ribas	285
7	CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire 2014 ·Clinical Cancer Research ·Lídia Robert, Jennifer Tsoi, Xiaoyan Wang, Ryan Emerson, Blanca Homet, Thinle Chodon, Stephen Mok, Rong Huang, Alistair J. Cochran, Begoña Comı́n-Anduix, Richard C. Koya, Thomas G. Graeber, (unknown), Antoni Ribas	280
8	HSV-sr39TK Positron Emission Tomography and Suicide Gene Elimination of Human Hematopoietic Stem Cells and Their Progeny in Humanized Mice 2014 ·Cancer Research ·Eric H. Gschweng, Melissa McCracken, Michael L. Kaufman, Michelle Ho, Roger P. Hollis, Xiaoyan Wang, (unknown), Richard C. Koya, Thinle Chodon, Antoni Ribas, Owen N. Witte, Donald B. Kohn	26
9	Exposure to a Histone Deacetylase Inhibitor Has Detrimental Effects on Human Lymphocyte Viability and Function 2014 ·Cancer Immunology Research ·Deborah J. Wong, (unknown), Earl Avramis, Douglas Matsunaga, Kimberly M. Komatsubara, Mohammad Atefi, Helena Escuin-Ordinas, Thinle Chodon, Richard C. Koya, Antoni Ribas, Begoña Comı́n-Anduix	17
10	Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy breakdown → 2013 ·Cancer Discovery ·Hubing Shi, Willy Hugo, Xiangju Kong, Aayoung Hong, Richard C. Koya, Gatien Moriceau, Thinle Chodon, Rongqing Guo, Douglas B. Johnson, Kimberly B. Dahlman, Mark C. Kelley, Richard Kefford, Bartosz Chmielowski, John A. Glaspy, Jeffrey A. Sosman, Nicolas van Baren, Georgina V. Long, Antoni Ribas, Roger S. Lo	715
11	Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy 2013 ·Cancer Discovery ·Chao Ma, Ann Cheung, Thinle Chodon, Richard C. Koya, Zhongqi Wu, Charles Ng, Earl Avramis, Alistair J. Cochran, Owen N. Witte, David Baltimore, Bartosz Chmielowski, James S. Economou, Begonya Comin-Anduix, Antoni Ribas, James R. Heath	112
12	A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition 2013 ·Cancer Discovery ·Hubing Shi, Aayoung Hong, Xiangju Kong, Richard C. Koya, Chunying Song, Gatien Moriceau, Willy Hugo, Clarissa C. Yu, Charles Ng, Thinle Chodon, Richard A. Scolyer, Richard Kefford, Antoni Ribas, Georgina V. Long, Roger S. Lo	133
13	Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab 2013 ·PLoS ONE ·F. Javier Ibarrondo, Otto O. Yang, Thinle Chodon, Earl Avramis, Yohan Lee, Hooman Sazegar, Jason Jalil, Bartosz Chmielowski, Richard C. Koya, Ingrid Schmid, Jesús Gómez-Navarro, Beth D. Jamieson, Antoni Ribas, Begoña Comı́n-Anduix	14
14	BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy 2012 ·Cancer Research ·Richard C. Koya, Stephen Mok, Nicholas Otte, (unknown), Begonya Comin-Anduix, Paul C. Tumeh, Aspram Minasyan, Nicholas A. Graham, Thomas G. Graeber, Thinle Chodon, Antoni Ribas	187
15	Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance breakdown → 2012 ·Nature Communications ·Hubing Shi, Gatien Moriceau, Xiangju Kong, Mi‐Kyung Lee, Hane Lee, Richard C. Koya, Charles Ng, Thinle Chodon, Richard A. Scolyer, Kimberly B. Dahlman, Jeffrey A. Sosman, Richard Kefford, Georgina V. Long, Stanley F. Nelson, Antoni Ribas, Roger S. Lo	470
16	Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses 2010 ·Proceedings of the National Academy of Sciences ·Richard C. Koya, Stephen Mok, Begoña Comı́n-Anduix, Thinle Chodon, Caius G. Radu, Michael I. Nishimura, Owen N. Witte, Antoni Ribas	48
17	Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation breakdown → 2010 ·Nature ·Ramin Nazarian, Hubing Shi, Qi Wang, Xiangju Kong, Richard C. Koya, Hane Lee, Zugen Chen, Mi‐Kyung Lee, Narsis Attar, Hooman Sazegar, Thinle Chodon, Stanley F. Nelson, Grant A. McArthur, Jeffrey A. Sosman, Antoni Ribas, Roger S. Lo	1614
18	Modulation of Cell Signaling Networks after CTLA4 Blockade in Patients with Metastatic Melanoma 2010 ·PLoS ONE ·Begoña Comı́n-Anduix, Hooman Sazegar, Thinle Chodon, Douglas Matsunaga, Jason Jalil, Erika von Euw, Helena Escuin-Ordinas, Robert Balderas, Bartosz Chmielowski, Jesús Gómez-Navarro, Richard C. Koya, Antoni Ribas	23
19	CTLA4 blockade increases Th17 cells in patients with metastatic melanoma 2009 ·Journal of Translational Medicine ·Erika von Euw, Thinle Chodon, Narsis Attar, Jason Jalil, Richard C. Koya, Begonya Comin-Anduix, Antoni Ribas	135
20	Keloid-Derived Fibroblasts Are Refractory to Fas-Mediated Apoptosis and Neutralization of Autocrine Transforming Growth Factor-β1 Can Abrogate this Resistance 2000 ·American Journal Of Pathology ·Thinle Chodon, Tsuneki Sugihara, Hiroharu H. Igawa, Emi Funayama, Hiroshi Furukawa	101

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact